Acro Biomedical (ACBM) Return on Sales (2017 - 2023)

Acro Biomedical has reported Return on Sales for 7 years, with the latest figure at 0.35% in Q3 2023.

• For the quarter ending Q3 2023, Return on Sales fell 18.0% year-over-year to 0.35%; the trailing twelve-month figure through Sep 2023 stood at 0.35% (down 18.0% YoY), and the FY2022 full-year result was 0.24%, down 18.0% from the prior year.
• Return on Sales for Q3 2023 stood at 0.35%, up from 0.42% in the prior quarter.
• The five-year high for Return on Sales was 0.0% in Q1 2020, with the low at 0.44% in Q1 2023.
• Average Return on Sales over 5 years is 0.12%, with a median of 0.06% recorded in 2021.
• Year-over-year, Return on Sales changed 0 bps in 2019 and sank 31 bps in 2023.
• Tracing ACBM's Return on Sales over 5 years: stood at 0.0% in 2019, then jumped by 62 bps to 0.0% in 2020, then plunged by 4213 bps to 0.06% in 2021, then sank by 70 bps to 0.11% in 2022, then slumped by 223 bps to 0.35% in 2023.
• The last three Return on Sales figures came in at 0.35% (Q3 2023), 0.42% (Q2 2023), and 0.44% (Q1 2023), per Business Quant data.

Peer Comparison